MitoCanada

Mitochondrial disease is complex and highly individualized, so it’s no surprise that nutrition research is moving toward more personalized, diagnosis-informed approaches. While we don’t yet have a single “best diet” for mitochondrial disease, growing evidence is helping clinicians better understand when nutrition strategies may be helpful, for whom, and why.

This is an encouraging direction. As research evolves, it strengthens the possibility of more refined nutrition guidance, better symptom management tools, and ultimately, improved quality of life for adults living with mito.

Another rapidly growing area is the connection between gut health, the microbiome, and mitochondrial function. A 2024 review focused specifically on mitochondrial disease highlights the “mitochondria-microbiome” connection and explores how diet and microbe-produced metabolites (small organic molecules produced during metabolism) may influence mitochondrial pathways, opening up new possibilities for supportive therapies and research.

For many adults with mito who experience gastrointestinal (GI) symptoms, this research is especially meaningful because it validates that GI function isn’t “separate” from energy, it may be part of the same interconnected system.

As mitochondrial disease represents over 350 different diagnoses, it makes sense that nutrition can play different roles depending on the underlying condition.

In some disorders, nutrition strategies are focused on preventing metabolic crisis; in others, the goal may be to reduce catabolic stress, support muscle health, or complement diagnosis-specific therapies. Broad clinical care standards emphasize individualized planning and avoiding metabolic stressors (like prolonged fasting), with diagnosis-specific guidance helping further shape nutrition approaches.

For FAOD, nutrition is often a central part of disease management. Because the body many not be able to use fats effectively for energy, maintaining a reliable fuel supply (often emphasizing carbohydrates) and avoiding fasting is critical. Clinical and guideline literature repeatedly highlights:

MELAS can involve high metabolic demand and multi-system symptoms (including GI and nutrition challenges), so nutrition strategies often emphasize maintaining energy balance and preventing catabolic stress during illness or poor intake.

Targeted supplementation is sometimes discussed in MELAS, most notably arginine and/or citrulline in relation to stroke-like episodes. The literature includes supportive reports and reviews, but consensus guidance also notes limitations and ongoing debate about strength of evidence and clinical use.

In MELAS, nutrition care often focuses on steady intake, illness-day planning, and discussing targeted therapies (like specific supplements) with a mitochondrial specialist because recommendations vary across clinics and individuals.

When muscle involvement is prominent, nutrition strategies often focus on supporting muscle maintenance and minimizing fatigue by ensuring adequate overall calories and protein, especially if appetite is low or unintentional weight loss is present.

Some research in mitochondrial disease populations (including those with muscle symptoms) suggests that insufficient intake is common, and that higher intakes of macronutrients (including protein) may correspond with better outcomes like muscle strength, lower fatigue, and improved quality of life, though this doesn’t mean “more is always better,” and personalization matters.

For mitochondrial myopathies, nutrition support often prioritizes “enough energy + enough protein,” using practical strategies (small frequent meals, energy-dense additions, smoothies) when fatigue or GI issues make intake difficult.

POLG-related disorders can present very differently from one person to another. Nutrition strategies commonly emphasize preventing catabolic stress (especially during illness or reduced intake) and maintaining consistent energy availability, an approach aligned with broader mitochondrial care standards.

In some POLG-related conditions, seizures can be a major concern, and dietary therapies (such as ketogenic-style approaches) may be considered in specialized contexts (typically for difficult-to-treat refractory epilepsy) under expert supervision, with careful monitoring and individualized risk–benefit discussions.

For POLG, the key nutrition themes are often “avoid catabolic stress, plan for illness, and create individualize dietary approaches with your mito specialist and care team,” especially if seizures or significant GI/nutrition issues are part of the picture.

Because mitochondrial disease includes many different conditions, nutrition approaches are rarely one-size-fits-all. Some disorders rely heavily on nutrition strategies to prevent metabolic crisis, while others focus on maintaining energy balance, supporting muscle health, or managing symptoms. Across many diagnoses, maintaining consistent energy intake and avoiding metabolic stress are key themes. Individualized guidance from a mitochondrial specialist or dietitian is important to determine the best approach.

Fasting can significantly change how the body fuels itself. When you go without food for longer periods, the body shifts away from using incoming carbohydrates and begins relying more on stored fuels (including fats, protein/muscle). For individuals living with mito, where energy production may already be less efficient, this shift can add metabolic stress and may worsen symptoms for some individuals.

Clinical care standards for mitochondrial disease specifically emphasize preventing catabolism (a state where the body breaks down stored energy and tissue) and recommend avoiding prolonged fasting, particularly around illness, procedures or other stressors.

Because mitochondrial disorders are highly variable, always consult the specialist overseeing your mitochondrial disease care before trying fasting, intermittent fasting or any restrictive eating approach. The “right” strategy must match the diagnosis and the individual, not what is trending online.

Some mitochondrial specialists may recommend a combination of vitamins and mitochondrial cofactors (nutrients that help enzymes do their jobs), often referred to as the mito cocktail. The goal of a mito cocktail is supportive, to help optimize mitochondrial function, reduce metabolic stress, and improve symptom management.

It’s important to know that there is no single standard mito cocktail. Supplement choices (if recommended at all) depend on an individual’s diagnosis, symptoms, age, medications and lab findings. Clinical experts emphasize that while strong randomized trial evidence is limited for many supplements, supplements are often used in practice because some have biologic rationale, relatively favourable safety profiles when monitored, and may be particularly relevant in specific mito conditions.

Specialists may consider supplements because they can help:

• Support energy production pathways (including oxidative phosphorylation)
• Provide cofactors needed for mitochondrial enzymes
• Help manage secondary effects of mitochondrial dysfunction (like oxidative stress)
• Address suspected or documented nutrient deficiencies

In some mitochondrial disorders, specific supplements are more commonly considered because of the underlying biology. For example, the Mitochondrial Medicine Society care standards note that riboflavin may be considered in ACAD9-related myopathy and that a combination of CoQ10 and riboflavin may be considered for ETFDH gene-related myopathy.

These are often discussed during mito clinc appointments and in patient resources, but not everyone needs them, and dosing/selection should be individualized.

There’s a fair amount of supplement information online that can sound very convincing. But with mitochondrial disease, the right supplement plan depends on the type of diagnosis and the right clinical context. Supplements can interact with medications, affect lab test results and, depending on the individual, may cause side effects.

Before starting, stopping or changing any supplement, it’s strongly recommended that you discuss it with the specialist overseeing your mitochondrial disease care.